Brooke Marie Matney
Examiner (ID: 13656)
Most Active Art Unit | 3763 |
Art Unit(s) | 3763, 4138 |
Total Applications | 196 |
Issued Applications | 132 |
Pending Applications | 0 |
Abandoned Applications | 64 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12009867
[patent_doc_number] => 09803174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-31
[patent_title] => 'Neural progenitor cell populations'
[patent_app_type] => utility
[patent_app_number] => 13/558078
[patent_app_country] => US
[patent_app_date] => 2012-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16129
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13558078
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/558078 | Neural progenitor cell populations | Jul 24, 2012 | Issued |
Array
(
[id] => 8670696
[patent_doc_number] => 20130045234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'NEUTRALIZING FACTORS AS VACCINE ADJUVANTS'
[patent_app_type] => utility
[patent_app_number] => 13/549883
[patent_app_country] => US
[patent_app_date] => 2012-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10230
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13549883
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/549883 | NEUTRALIZING FACTORS AS VACCINE ADJUVANTS | Jul 15, 2012 | Abandoned |
Array
(
[id] => 8618341
[patent_doc_number] => 20130023653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'Tissue Specific Expression Of Antibodies In Chickens'
[patent_app_type] => utility
[patent_app_number] => 13/550488
[patent_app_country] => US
[patent_app_date] => 2012-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15981
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13550488
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/550488 | Tissue specific expression of antibodies in chickens | Jul 15, 2012 | Issued |
Array
(
[id] => 8467176
[patent_doc_number] => 20120272344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'TRANSGENIC ANIMALS EXPRESSING CHIMERIC ANTIBODIES FOR USE IN PREPARING HUMAN ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 13/540386
[patent_app_country] => US
[patent_app_date] => 2012-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16422
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13540386
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/540386 | Transgenic animals expressing chimeric antibodies for use in preparing human antibodies | Jul 1, 2012 | Issued |
Array
(
[id] => 8891142
[patent_doc_number] => 20130164326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'CHIMERIC ADENOVIRAL VECTORS'
[patent_app_type] => utility
[patent_app_number] => 13/532701
[patent_app_country] => US
[patent_app_date] => 2012-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15728
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13532701
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/532701 | Chimeric adenoviral vectors | Jun 24, 2012 | Issued |
Array
(
[id] => 8779651
[patent_doc_number] => 20130101625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'MODIFIED CEA NUCLEIC ACID AND EXPRESSION VECTORS'
[patent_app_type] => utility
[patent_app_number] => 13/532035
[patent_app_country] => US
[patent_app_date] => 2012-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13601
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13532035
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/532035 | Modified CEA nucleic acid and expression vectors | Jun 24, 2012 | Issued |
Array
(
[id] => 9572183
[patent_doc_number] => 20140189897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'TRANSGENIC ANIMALS CAPABLE OF BEING INDUCED TO DELETE SENESCENT CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/125841
[patent_app_country] => US
[patent_app_date] => 2012-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8231
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125841
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125841 | TRANSGENIC ANIMALS CAPABLE OF BEING INDUCED TO DELETE SENESCENT CELLS | Jun 20, 2012 | Abandoned |
Array
(
[id] => 8670955
[patent_doc_number] => 20130045492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain'
[patent_app_type] => utility
[patent_app_number] => 13/488628
[patent_app_country] => US
[patent_app_date] => 2012-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 41343
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13488628
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/488628 | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain | Jun 4, 2012 | Abandoned |
Array
(
[id] => 8832045
[patent_doc_number] => 20130133090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'TRANSGENIC MAMMALLS MODIFIED IN BRI PROTEIN EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 13/477397
[patent_app_country] => US
[patent_app_date] => 2012-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12821
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13477397
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/477397 | TRANSGENIC MAMMALLS MODIFIED IN BRI PROTEIN EXPRESSION | May 21, 2012 | Abandoned |
Array
(
[id] => 8489065
[patent_doc_number] => 20120288472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'REGULATION OF T CELL-MEDIATED IMMUNITY BY TRYPTOPHAN'
[patent_app_type] => utility
[patent_app_number] => 13/476183
[patent_app_country] => US
[patent_app_date] => 2012-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15184
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13476183
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/476183 | REGULATION OF T CELL-MEDIATED IMMUNITY BY TRYPTOPHAN | May 20, 2012 | Abandoned |
Array
(
[id] => 8994817
[patent_doc_number] => 08518701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Methods and materials for producing transgenic artiodactyls'
[patent_app_type] => utility
[patent_app_number] => 13/467588
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 11
[patent_no_of_words] => 16961
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467588
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/467588 | Methods and materials for producing transgenic artiodactyls | May 8, 2012 | Issued |
Array
(
[id] => 8453166
[patent_doc_number] => 20120264112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY'
[patent_app_type] => utility
[patent_app_number] => 13/456330
[patent_app_country] => US
[patent_app_date] => 2012-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4544
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13456330
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/456330 | METHOD OF MEASURING HUMAN CYP3A INDUCIBILITY | Apr 25, 2012 | Abandoned |
Array
(
[id] => 9517733
[patent_doc_number] => 20140154225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'METHOD FOR COMBINED CONDITIONING AND CHEMOSELECTION IN A SINGLE CYCLE'
[patent_app_type] => utility
[patent_app_number] => 14/112878
[patent_app_country] => US
[patent_app_date] => 2012-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11465
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112878
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112878 | Method for combined conditioning and chemoselection in a single cycle | Apr 19, 2012 | Issued |
Array
(
[id] => 8495936
[patent_doc_number] => 20120295344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'Stem Cell Fusion Model of Carcinogenesis'
[patent_app_type] => utility
[patent_app_number] => 13/448251
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12803
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448251
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/448251 | Stem Cell Fusion Model of Carcinogenesis | Apr 15, 2012 | Abandoned |
Array
(
[id] => 8335101
[patent_doc_number] => 20120201808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'Stem Cell Fusion Model of Carcinogenesis'
[patent_app_type] => utility
[patent_app_number] => 13/448112
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6827
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448112
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/448112 | Stem cell fusion model of carcinogenesis | Apr 15, 2012 | Issued |
Array
(
[id] => 8699329
[patent_doc_number] => 20130061338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'SCREENING OF DRUG FOR ATTENTION DEFICIT HYPERACTIVE DISORDER BY USING GIT1 KNOCK-OUT MICE AS A NOVEL ADHD MOUSE MODEL'
[patent_app_type] => utility
[patent_app_number] => 13/446789
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5568
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446789
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/446789 | Screening of drug for attention deficit hyperactive disorder by using GIT1 knock-out mice as a novel ADHD mouse model | Apr 12, 2012 | Issued |
Array
(
[id] => 9437819
[patent_doc_number] => 20140115726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'NEW TALE-PROTEIN SCAFFOLDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/009509
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 35113
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009509
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/009509 | NEW TALE-PROTEIN SCAFFOLDS AND USES THEREOF | Apr 4, 2012 | Abandoned |
Array
(
[id] => 8315290
[patent_doc_number] => 20120192300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'Common Light Chain Mouse'
[patent_app_type] => utility
[patent_app_number] => 13/412936
[patent_app_country] => US
[patent_app_date] => 2012-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 34453
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412936
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/412936 | Common Light Chain Mouse | Mar 5, 2012 | Abandoned |
Array
(
[id] => 8670642
[patent_doc_number] => 20130045180
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2013-02-21
[patent_title] => 'VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/360389
[patent_app_country] => US
[patent_app_date] => 2012-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30629
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360389
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/360389 | VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME | Jan 26, 2012 | Abandoned |
Array
(
[id] => 8670642
[patent_doc_number] => 20130045180
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2013-02-21
[patent_title] => 'VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/360389
[patent_app_country] => US
[patent_app_date] => 2012-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30629
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360389
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/360389 | VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME | Jan 26, 2012 | Abandoned |